Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (281-290 of 534) with videos related to

Pageof 54
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2022
Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening SpecimensKevin C Ma, Jaime E Hale, Yonatan H Grad, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
Outflanking immunodominance to target subdominant broadly neutralizing epitopesDavide Angeletti, Ivan Kosik, Jefferson J S Santos, et al.
Science Translational Medicine|October 19, 2021
COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant womenCaroline Atyeo, Elizabeth A DeRiso, Christine Davis, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Shigella O-specific polysaccharide functional IgA responses mediate protection against shigella infection in an endemic high-burden settingBiana Bernshtein, Meagan Kelly, Deniz Cizmeci, et al.
The Journal of Infectious Diseases|October 5, 2010
Determinants of protection among HIV‐exposed seronegative persons: an overviewMichael M Lederman, Galit Alter, Demetre C Daskalakis, et al.
Plos Computational Biology|April 16, 2015
Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccineesIckwon Choi, Amy W Chung, Todd J Suscovich, et al.
Communications Medicine|May 26, 2023
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamstersCatherine Berry, Vincent Pavot, Natalie G Anosova, et al.
Medrxiv : the Preprint Server for Health Sciences|July 2, 2020
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Vaccines|April 23, 2022
Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent ChildrenMadeleine D Burns, Brittany P Boribong, Yannic C Bartsch, et al.
Journal of Virology|September 14, 2018
Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in HumansFranco Pissani, Bianca Schulte, Michael A Eller, et al.
Pageof 54

Showing results (281-290 of 534) with videos related to

Sort By:
Pageof 54
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2022
Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening SpecimensKevin C Ma, Jaime E Hale, Yonatan H Grad, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
Outflanking immunodominance to target subdominant broadly neutralizing epitopesDavide Angeletti, Ivan Kosik, Jefferson J S Santos, et al.
Science Translational Medicine|October 19, 2021
COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant womenCaroline Atyeo, Elizabeth A DeRiso, Christine Davis, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Shigella O-specific polysaccharide functional IgA responses mediate protection against shigella infection in an endemic high-burden settingBiana Bernshtein, Meagan Kelly, Deniz Cizmeci, et al.
The Journal of Infectious Diseases|October 5, 2010
Determinants of protection among HIV‐exposed seronegative persons: an overviewMichael M Lederman, Galit Alter, Demetre C Daskalakis, et al.
Plos Computational Biology|April 16, 2015
Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccineesIckwon Choi, Amy W Chung, Todd J Suscovich, et al.
Communications Medicine|May 26, 2023
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamstersCatherine Berry, Vincent Pavot, Natalie G Anosova, et al.
Medrxiv : the Preprint Server for Health Sciences|July 2, 2020
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Vaccines|April 23, 2022
Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent ChildrenMadeleine D Burns, Brittany P Boribong, Yannic C Bartsch, et al.
Journal of Virology|September 14, 2018
Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in HumansFranco Pissani, Bianca Schulte, Michael A Eller, et al.
Pageof 54